grant

Levels of evidence for surrogate therapeutics [ 2008 - 2012 ]


Funded by National Health and Medical Research Council
Managed by The University of New South Wales
Managed by University of New South Wales
Provided by   National Health and Medical Research Council

Research Grant

[Cite as http://purl.org/au-research/grants/nhmrc/510272]

Researchers: Prof Marissa Lassere (Principal investigator) ,  Dr Kent Johnson ,  Dr Sally Galbraith ,  Prof Michael Hughes ,  Prof Robyn Ward
View all 6 related researchers

Brief description This project aims to establish agreement on appropriate methods to analyse evidence in support of medical treatments directed at laboratory tests (such as blood cholesterol) and to classify the evidence according to how convincing it is. The goal of those developing new drugs targeting one of these laboratory tests is to have their evidence sufficiently convincing that the drug will be approved for sale and used because doctors and patients believe its use will translate into a patient benefit.

Funding Amount $AUD 536,207.38

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Help

Related Organisations

Related People

Subjects
Biomedical and Clinical Sciences | Other Biomedical and Clinical Sciences | Other Biomedical and Clinical Sciences Not Elsewhere Classified | biological markers | clinical classification | clinical effectiveness and evidence based medicine | clinical epidemiology | clinical patient management | drug development | levels of evidence | multivariate statistics | surrogate markers | therapeutic targets |
Identifiers
Viewed: [[ro.stat.viewed]]
Saved to MyRDA Save to MyRDA